Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.
about
IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravisPrioritizing genes of potential relevance to diseases affected by sex hormones: an example of myasthenia gravisRegulatory T cells in multiple sclerosis and myasthenia gravis.Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.Extraocular muscle characteristics related to myasthenia gravis susceptibility.Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravisAnalysis of serum miRNA profiles of myasthenia gravis patients.Effect of complement and its regulation on myasthenia gravis pathogenesis.John Newsom-Davis: clinician-scientist and so much more.Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patientsC5a is not involved in experimental autoimmune myasthenia gravis pathogenesis.A rhabdomyoma within a multilocular thymic cyst in a p53-null mouse.Autoimmune myasthenia gravis: emerging clinical and biological heterogeneityAutoantibodies in neuromuscular transmission disorders.Diagnostic use of autoantibodies in myasthenia gravis.Thymoma and paraneoplastic myasthenia gravis.Thymic remodeling associated with hyperplasia in myasthenia gravis.The thymus in myasthenia gravis: Site of "innate autoimmunity"?Targeting the fetal acetylcholine receptor in rhabdomyosarcoma.Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?Thymus pathology observed in the MGTX trial.Inflammation and epstein-barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis.Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis.Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis.Development of humanized scFv antibody fragment(s) that targets and blocks specific HLA alleles linked to myasthenia gravis.Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms.Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis
P2860
Q24648462-AF09D8DC-2F78-48F6-9714-1802362234EFQ30484806-763135D0-6AC2-426D-B839-7550E3745412Q33784969-317A3A95-40F2-4DEA-8495-2ADDE18DC5BFQ34043022-A7C19A89-D098-4BF1-880B-7638BE9B99E2Q34503367-BF51F636-A818-4DFE-8A09-AAA5EB3E70C8Q34586123-5FB83EB2-7A7D-4540-9FCF-075643BB06FCQ35049295-DE59A3D5-AA5D-4A27-824A-133BB8D3783DQ35122838-4690928E-A1AC-4CEE-A859-236AEF7B74A3Q35221722-944FA709-1724-4617-A754-FE6FB2755C4CQ35606729-E0E639E8-83C7-4B99-A60A-DEB9FF41E5DCQ35948555-1AD6C6BF-72D6-4EF7-B606-8442CD4C592AQ36820909-32ED7528-1B09-4DDD-93A5-E302364407B7Q36838946-1ECD4ADC-4664-45E6-910E-9046DE26C143Q37315963-0104FBAD-3EBB-4A79-98DE-C73237C8C567Q37409082-9BE470E6-6C53-440A-8F26-F18F674D74AEQ37727987-110FC902-6524-4F0E-B468-2D6B2801E332Q37727991-0A95CBAE-014D-4872-BD67-84E711E7D80DQ37733580-FEF65C21-E80F-460B-BE71-A65C0520A12DQ37933171-AC485DFB-56B4-4C31-BFEF-9713132F1E30Q38066542-062AB0B1-C1B5-499F-8944-A63DE48BE179Q38068534-9E857562-B929-497D-8081-FE1A7518F4DCQ38070759-574D3757-2AFD-4F0E-ABC7-64F12132FCC8Q38562557-6DDBFD53-F6FF-4501-92D4-99854CB1DBC6Q41433464-3CE2580B-3308-4393-9E43-E97CB771B2DFQ44316843-B368EAE6-35F2-4686-982C-CA7E7B7CD1DBQ47442517-1CA5AC0E-D542-41DA-B8C8-DBBD6CC51BDDQ48339804-AAEB351E-B021-462E-AE0E-D8C1585FE116Q50853916-9F3320C7-C79A-481A-B6EE-B60197D55679Q58803309-BEAF63CF-7B94-42FD-8C89-4594F5692EFE
P2860
Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Myasthenia gravis thymus: comp ...... ions with autoantibody status.
@ast
Myasthenia gravis thymus: comp ...... ions with autoantibody status.
@en
type
label
Myasthenia gravis thymus: comp ...... ions with autoantibody status.
@ast
Myasthenia gravis thymus: comp ...... ions with autoantibody status.
@en
prefLabel
Myasthenia gravis thymus: comp ...... ions with autoantibody status.
@ast
Myasthenia gravis thymus: comp ...... ions with autoantibody status.
@en
P2093
P2860
P50
P1476
Myasthenia gravis thymus: comp ...... tions with autoantibody status
@en
P2093
Alexander Marx
Angela Vincent
Aurea Canelhas
Francesco Scaravilli
Margaret Jones
Maria I Leite
Nick Willcox
Philipp Ströbel
P2860
P304
P356
10.2353/AJPATH.2007.070240
P407
P577
2007-08-03T00:00:00Z